UPDATE 1-S.Africa’s Aspen sells thrombosis drug business to Mylan, shares jump

[ad_1] (Adds details) JOHANNESBURG, Sept 8 (Reuters) – South African drugmaker Aspen Pharmacare has agreed to sell the rights to its European thrombosis business to U.S. pharmaceutical company Mylan for…

New Technology Developments in Cerebral Vein Thrombosis Treatment Market Business Outlook, Critical Insight,Opportunities, Regional Overview,Business Strategies and Industry Size Forecast to 2030

[ad_1] Business Overview Financial Data Financial – Funding Recent Development and Company Strategy AnalysisContact Us: Stratagem Market Insights UK: +44-203-289-4040 Email: [email protected]